The pre-seed round was backed by participants including Y Combinator and the UK government.
"The discovery of novel pharmaceuticals is one of our most important weapons in fighting disease. However, the drug development pipeline is often driven by trial-and-error and held up for many months during the identification of scalable manufacturing processes, delaying clinical trials. Our AI-powered models learn from historical data, cutting up to 95% of experimental work and accelerating these workflows by 30x."
The funding round was backed by the Midlands Engine Investment Fund, Mercia Ventures, and Pioneer Group.
"Our mission is to help companies avoid unnecessary animal testing and provide more accurate and relevant test results. This latest funding will enable us to continue building our range of tests and assays and use our model for different purposes, across different industries. We will also continue engaging with regulators to adapt industry standards tests to become animal free, and establish ImmuONE as a leading provider."
The funding round was led by The FSE Group and included participation from the South West Investment Fund.
"We see too many people who are undergoing treatment or suffering from conditions, who don't understand what's going on, which increases their anxiety. It also increases the demands they make on their health systems and services around them. It's not fair, and it's not necessary."
Project A led the round with participation from returning investors Northzone and Seedcamp.
"At Mimo, we’ve been continually learning from these conversations to iterate and improve the platform to help both Accountants and SMBs save time, save money and control their cash flow. We look forward to working with new investors Project A and returning investors Northzone and Seedcamp as we strive towards this goal."
-20webclip.png)
